ACRAcruxACR info
$0.02info6.25%24h
Global rank
Market cap$6.13M
Change 7d0.00%
YTD Performance-
SP500 benchmark
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Acrux (ACR) Stock Overview

    Acrux Limited, together with its subsidiaries, develops and commercializes generic and topical pharmaceuticals in Australia, Europe, the United States, and internationally. The company offers testosterone solutions, such as oral tablets, buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels for treatment of males. It also provides estradiol transdermal sprays for women under the Evamist and Lenzetto brand names for the treatment of flushes associated with menopause; and lidocaine and prilocaine cream, a generic version of EMLA cream, which is indicated as a topical anaesthetic for use on normal intact skin for local analgesia, and genital mucous membranes for superficial minor surgery and as a pre-treatment for infiltration anaesthesia. The company was incorporated in 1998 and is based in West Melbourne, Australia.

    ACR Stock Information

    Symbol
    ACR
    Address
    103-113, Stanley StreetWest Melbourne, VIC 3003Australia
    Founded
    -
    Trading hours
    10:00 AM - 4:00 PM AEST
    Website
    https://www.acrux.com.au
    Country
    🇦🇺 Australia
    Phone Number
    61 3 8379 0100

    Acrux (ACR) Price Chart

    -
    Value:-

    Acrux Overview: Key Details and Summary

    Stock data
    2025
    Change
    Price
    $0.021174698727649797
    N/A
    Market Cap
    $6.13M
    N/A
    Shares Outstanding
    289.63M
    N/A
    Employees
    0
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2025 Topstocks.org